Table 1.
n = 51 | Value |
---|---|
Age (years) | |
Median [range] | 50.8 [21.2; 75.3] |
Female gender n (%) | 23 (45) |
Primary histopathological type n (%) | |
IDH-mutant astrocytoma | 8 (16) |
IDH-wildtype astrocytoma | 6 (12) |
IDH-mutant and 1p/19q co-deleted oligodendroglioma | 12 (24) |
IDH-wildtype glioblastoma | 22 (43) |
IDH-mutant glioblastoma | 3 (6) |
Histopathological WHO grade of the primary tumor n (%) | |
II | 18 (35) |
III | 8 (16) |
IV | 25 (49) |
Primary treatment n (%) | |
Surgery | 15 (29) |
Surgery + radiotherapy | 2 (4) |
Surgery + chemotherapy | 9 (18) |
Surgery + radiotherapy + chemotherapy | 25 (49) |
WHO World Health Organization